Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.

@article{Deng2008SynthesisOQ,
  title={Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.},
  author={Kai Deng and M. Adams and Payal Damani and P. Livingston and G. Ragupathi and D. Gin},
  journal={Angewandte Chemie},
  year={2008},
  volume={47 34},
  pages={
          6395-8
        }
}
  • Kai Deng, M. Adams, +3 authors D. Gin
  • Published 2008
  • Medicine
  • Angewandte Chemie
  • The success of antitumor and antiviral vaccines often requires the use of an adjuvant, a substance that is itself not necessarily immunogenic but significantly enhances the immune response of a patient to a coadministered antigen.[1] The adjuvant of choice in many recent immunotherapeutic advances against cancer,[2] human immunodeficiency virus,[3, 4] and malaria[5, 6] is the natural product saponin QS-21.[7] Extensive studies in the development of conjugate cancer vaccines demonstrated the… CONTINUE READING
    47 Citations
    Design and synthesis of potent Quillaja saponin vaccine adjuvants.
    • 61
    Development of a minimal saponin vaccine adjuvant based on QS-21
    • 45
    Synthesis of QS-21-based immunoadjuvants.
    • 9
    Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21.
    • 4
    Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.
    • 31

    References

    SHOWING 1-10 OF 20 REFERENCES
    Isomerization and formulation stability of the vaccine adjuvant QS-21.
    • 74
    Saponins as vaccine adjuvants.
    • 202
    Synthetic vaccines: the role of adjuvants in immune targeting.
    • 91
    Cancer Vaccines Targeting Carbohydrate Antigens
    • 34